Keywords: hyseq, cd39-l4, potential, mi, inc, experimental, drug

Hyseq's CD39-L4: potential in MI?

Article | 14 July 1999

Hyseq Inc's experimental drug candidate CD39-L4 has potential in thetreatment and prevention of cardiovascular diseases, according to an article ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Adenocard

Adenosine

Go to drug listing